Across TCGA pan-cancer cohorts, MIR4500HG RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR4500HG data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR4500HG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR4500HG expression acts as an unfavorable survival marker, although some lineages such as KIRP and LGG show a favorable association.
KIRP, KICH, and LGG are the cancer types where MIR4500HG RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.